Susquehanna International Group, LLP Medpace Holdings, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$320.58 - $457.29 $320,580 - $457,290	-1,000 Reduced 8.06%	11,400 $3.8 Million
Q2 2024 Aug 15, 2024	SELL	$372.0 - $424.34 $25.9 Million - $29.6 Million	-69,700 Reduced 84.9%	12,400 $5.11 Million
Q1 2024 May 07, 2024	BUY	$284.87 - $413.31 $19.1 Million - $27.7 Million	67,000 Added 443.71%	82,100 $33.2 Million
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $887,328 - $1.22 Million	-3,900 Reduced 20.53%	15,100 $4.63 Million
Q3 2023 Nov 14, 2023	SELL	$233.98 - $281.67 $1.43 Million - $1.72 Million	-6,100 Reduced 24.3%	19,000 $4.6 Million
Q2 2023 Aug 11, 2023	BUY	$187.26 - $240.17 $3.95 Million - $5.07 Million	21,100 Added 527.5%	25,100 $6.03 Million
Q1 2023 May 16, 2023	SELL	$174.31 - $239.52 $2.25 Million - $3.09 Million	-12,900 Reduced 76.33%	4,000 $752,000
Q4 2022 Feb 14, 2023	SELL	$153.06 - $226.57 $6.41 Million - $9.49 Million	-41,900 Reduced 71.26%	16,900 $3.59 Million
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $333,799 - $419,727	2,300 Added 4.07%	58,800 $9.24 Million
Q2 2022 Aug 15, 2022	BUY	$130.2 - $168.03 $5.36 Million - $6.92 Million	41,200 Added 269.28%	56,500 $8.46 Million
Q1 2022 May 16, 2022	BUY	$138.87 - $214.31 $1.51 Million - $2.34 Million	10,900 Added 247.73%	15,300 $2.5 Million
Q4 2021 Feb 14, 2022	SELL	$182.74 - $227.9 $4.48 Million - $5.58 Million	-24,500 Reduced 84.78%	4,400 $958,000
Q3 2021 Nov 15, 2021	SELL	$170.18 - $198.21 $510,540 - $594,630	-3,000 Reduced 9.4%	28,900 $5.47 Million
Q2 2021 Aug 11, 2021	BUY	$158.62 - $194.3 $3.22 Million - $3.94 Million	20,300 Added 175.0%	31,900 $5.63 Million
Q1 2021 May 17, 2021	BUY	$132.02 - $168.26 $171,626 - $218,738	1,300 Added 12.62%	11,600 $1.9 Million
Q4 2020 Feb 16, 2021	BUY	$109.38 - $149.19 $426,582 - $581,841	3,900 Added 60.94%	10,300 $1.43 Million
Q3 2020 Nov 16, 2020	SELL	$92.95 - $130.61 $390,390 - $548,562	-4,200 Reduced 39.62%	6,400 $715,000
Q2 2020 Aug 14, 2020	SELL	$68.08 - $95.68 $803,344 - $1.13 Million	-11,800 Reduced 52.68%	10,600 $986,000
Q1 2020 May 15, 2020	BUY	$61.71 - $101.95 $351,747 - $581,115	5,700 Added 34.13%	22,400 $1.64 Million
Q4 2019 Feb 14, 2020	SELL	$70.08 - $84.64 $28,032 - $33,856	-400 Reduced 2.34%	16,700 $1.4 Million
Q3 2019 Nov 14, 2019	SELL	$62.38 - $85.89 $442,898 - $609,819	-7,100 Reduced 29.34%	17,100 $1.44 Million
Q2 2019 Aug 14, 2019	SELL	$53.64 - $65.42 $1.37 Million - $1.67 Million	-25,500 Reduced 51.31%	24,200 $1.58 Million
Q1 2019 May 15, 2019	SELL	$49.38 - $70.58 $59,256 - $84,696	-1,200 Reduced 2.36%	49,700 $2.93 Million
Q4 2018 Feb 14, 2019	BUY	$46.97 - $63.98 $333,487 - $454,258	7,100 Added 16.21%	50,900 $2.69 Million
Q3 2018 Nov 14, 2018	BUY	$43.25 - $63.74 $1.39 Million - $2.05 Million	32,200 Added 277.59%	43,800 $2.62 Million
Q2 2018 Aug 14, 2018	SELL	$34.03 - $45.46 $112,299 - $150,018	-3,300 Reduced 22.15%	11,600 $499,000
Q1 2018 May 15, 2018	BUY	$32.03 - $39.05 $477,247 - $581,845	14,900 New	14,900 $520,000

Others Institutions Holding MEDP

# of Institutions

617

Shares Held

25.1M

Call Options Held

42.8K

Put Options Held

207K

Black Rock Inc. New York, NY

2.58M
Shares

$899 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

2.55M
Shares

$887 Million
0.02% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

909K
Shares

$317 Million
1.51% of portfolio
State Street Corp Boston, MA

753K
Shares

$262 Million
0.01% of portfolio
Geode Capital Management, LLC Boston, MA

628K
Shares

$219 Million
0.02% of portfolio

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account